Does Entresto (sacubitril/valsartan) harm kidney function?
Entresto can affect kidney function because it contains valsartan, an angiotensin receptor blocker (ARB). Drugs in this class can reduce filtration pressure in the kidney, so blood tests may change—most notably creatinine, and sometimes potassium.
That said, ARB therapy is also commonly used in heart failure and kidney outcomes are often monitored closely rather than assumed to be uniformly harmful. Whether Entresto is “bad for your kidneys” depends on your baseline kidney function, your potassium level, and what other medicines you take.
What changes in labs are most concerning?
The two main kidney-related issues clinicians watch with Entresto are:
- Higher creatinine (which can signal reduced kidney filtration or a medication-related effect)
- Higher potassium (hyperkalemia), which can be dangerous and may also reflect kidney stress or impaired potassium excretion
If creatinine rises significantly after starting or increasing the dose, or if potassium becomes elevated, clinicians may reduce the dose, stop the drug, or adjust other medications.
Who is at higher risk of kidney problems on Entresto?
Risk is higher if you already have chronic kidney disease or factors that commonly raise potassium or stress the kidneys, such as:
- Poor baseline kidney function (lower estimated glomerular filtration rate)
- High baseline potassium
- Dehydration or low blood pressure
- Concurrent medicines that also raise potassium or affect kidney blood flow
Examples of medicines that can raise potassium or interact with kidney function include potassium supplements, some diuretics (especially mineralocorticoid receptor antagonists like spironolactone/eplerenone), and other agents that block the renin-angiotensin system.
What do doctors typically do to keep kidneys safe?
Clinicians usually manage risk by:
- Checking kidney function and potassium before starting
- Rechecking after starting or after dose changes
- Adjusting dose if potassium or creatinine rise
- Avoiding or limiting interacting medications where possible
If you notice reduced urination, sudden swelling, unusual weakness, or symptoms of high potassium (which can include muscle weakness or abnormal heart rhythms), you should seek medical advice promptly.
Can Entresto be protective or neutral for kidneys in heart failure?
In many patients with heart failure, the goal is not to “avoid kidney effects at all costs,” but to use therapies that improve cardiovascular outcomes while monitoring kidney safety. ARB-based regimens can still be appropriate even with kidney disease, provided monitoring and dose adjustments are done.
So the more accurate framing is: Entresto may worsen kidney labs in some people, but it can still be used safely with proper monitoring when the benefits outweigh the risks.
What should you ask your clinician if you have kidney disease?
If you have known kidney disease or borderline labs, practical questions include:
- What were my most recent creatinine and potassium?
- What lab recheck timing do you want after starting or changing Entresto?
- What potassium level would trigger dose reduction or stopping?
- Which of my meds or supplements might increase potassium?
If you share your most recent kidney numbers (creatinine or eGFR and potassium) and your current medication list, I can help you interpret how those factors commonly affect Entresto safety decisions.